Page 63 - MI-2-4

Microbes & Immunity Management of obesity

to 2014: A pooled analysis of 1698 population-based 13. Khan MJ, Gerasimidis K, Edwards CA, Shaikh MG.
measurement studies with 19.2 million participants. Lancet. Role of gut microbiota in the aetiology of obesity:
2016;387:1377e96. Proposed mechanisms and review of the literature. J Obes.
2016;2016:7353642.
doi: 10.1016/S0140-6736(16)30472-X
doi: 10.1155/2016/7353642
2. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden
of obesity in 2005 and projections to 2030. Int J Obes (Lond). 14. Tolhurst G, Heffron H, Lam YS, et al. Short-chain
2008;32:1431-1437. fatty acids stimulate glucagon-like peptide-1 secretion
via the G-protein-coupled receptor FFAR2. Diabetes.
doi: 10.1038/ijo.2008.102
2012;61(2):364-371.
3. Haslam DW, James WP. Obesity. Lancet. 2005;366:1197- doi: 10.2337/db11-1019
1209.
15. Softic S, Cohen DE, Kahn CR. Role of dietary fructose and
doi: 10.1016/S0140-6736(05)67483-1 hepatic de novo lipogenesis in fatty liver disease. Dig Dis Sci.
4. Ghosh S, Bouchard C. Convergence between biological, 2016;61(5):1282-1293.
behavioural and genetic determinants of obesity. Nat Rev doi: 10.1007/s10620-016-4054-0
Genet. 2017;18:731-748.
16. Da Silva HE, Teterina A, Comelli EM, et al. Nonalcoholic
doi: 10.1038/nrg.2017.72 fatty liver disease is associated with dysbiosis independent of
5. Hruby A, Hu FB. The epidemiology of obesity: A big picture. body mass index and insulin resistance. Sci Rep. 2018;8:1466.
Pharmacoeconomics. 2015;33:673-689. doi: 10.1038/s41598-018-19753-9
doi: 10.1038/nrmicro3089 17. Beaumont M, Neyrinck AM, Olivares M, et al. The gut
6. Zhao L. The gut microbiota and obesity: From correlation to microbiota metabolite indole alleviates liver inflammation
causality. Nat Rev Microbiol. 2013;11:639-647. in mice. FASEB J. 2018;32(10):5445-5455.
doi: 10.1038/nrmicro3089 doi: 10.1096/fj.201800544
7. Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an 18. Matsubara T, Li F, Gonzalez FJ. FXR signaling in
environmental factor that regulates fat storage. Proc Natl the enterohepatic system. Mol Cell Endocrinol. 2013;
Acad Sci U S A. 2004;101(44):15718-15723. 368(1-2):17-29.
doi: 10.1073/pnas.0407076101 doi: 10.1016/j.mce.2012.05.004
8. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, 19. Harrison SA, Rinella ME, Abdelmalek MF, et al. NGM282 for
Gordon JI. Obesity alters gut microbial ecology. Proc Natl treatment of non-alcoholic steatohepatitis: A multicentre,
Acad Sci U S A. 2005;102:11070-11075. randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet. 2018;391(10126):1174-1185.
doi: 10.1073/pnas.0504978102
doi: 10.1016/S0140-6736(18)30474-4
9. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V,
Mardis ER, Gordon JI. An obesity-associated gut 20. Trabelsi MS, Daoudi M, Prawitt J, et al. Farnesoid X
microbiome with increased capacity for energy harvest. receptor inhibits glucagon-like peptide-1 production by
Nature. 2006;444(7122):1027-1031. enteroendocrine L cells. Nat Commun. 2015;6:7629.
doi: 10.1038/ncomms8629
doi: 10.1038/nature05414.
21. Wang L, Ren B, Zhang Q, et al. Methionine restriction
10. Martins Dos Santos V, Müller M, De Vos W. Systems biology
of the gut: The interplay of food, microbiota and host at the alleviates high-fat diet-induced obesity: Involvement of
mucosal interface. Curr Opin Biotechnol. 2010;21(4):539-550. diurnal metabolism of lipids and bile acids. Biochim Biophys
Acta Mol Basis Dis. 2020;1866(11):165908.
doi: 10.1016/j.copbio.2010.08.003
doi: 10.1016/j.bbadis.2020.165908
11. Rajani C, Jia W. Disruptions in gut microbial-host
co-metabolism and the development of metabolic disorders. 22. Huang ZR, Deng JC, Li QY, et al. Protective mechanism
Clin Sci (Lond). 2018;132(7):791-811. of common buckwheat (Fagopyrum esculentum Moench.)
against nonalcoholic fatty liver disease associated with
doi: 10.1042/CS20171328 dyslipidemia in mice fed a high-fat and high-cholesterol
12. Agus A, Clemen TK, Soko LH. Gut microbiota-derived diet. J Agric Food Chem. 2020;68(24):6530-6543.
metabolites as central regulators in metabolic disorders. doi: 10.1021/acs.jafc.9b08211
Gut. 2021;70(6):1174-1182.
23. Yaron JR, Gangaraju S, Rao MY, et al. K(+) regulates Ca(2+)
doi: 10.1136/gutjnl-2020-323071 to drive inflammasome signaling: Dynamic visualization of

Volume 2 Issue 4 (2025) 55 doi: 10.36922/MI025160036